Innocoll files IND application for CollaRx (Pharmaceutical Business Review)
Innocoll Technologies, a subsidiary of Innocoll, has filed an investigational new drug application for its CollaRx bupivacaine topical, which is under development for the treatment of painful chronic skin ulcers and burns.